Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer-Reference-Cited by-同舟云学术

Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer

Published:2019-04-29 Issue:1 Volume:17 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Isnaldi Edoardo,Garuti Anna,Cirmena Gabriella,Scabini Stefano,Rimini Edoardo,Ferrando Lorenzo,Lia Michela,Murialdo Roberto,Tixi Lucia,Carminati Enrico,Panaro Andrea,Gallo Maurizio,Grillo Federica,Mastracci Luca,Repetto Lazzaro,Fiocca Roberto,Romairone Emanuele,Zoppoli Gabriele^ORCID,Ballestrero Alberto

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-019-1879-2.pdf

Reference46 articles.

1. Ballestrero A, Garuti A, Cirmena G, Rocco I, Palermo C, Nencioni A, et al. Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. Curr Cancer Drug Targets. 2012;12(4):316–28.

2. Karapetis CS, Khambata-Ford S, Jonker DJ, O’Callaghan CJ, Tu D, Tebbutt NC, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008;359(17):1757–65.

3. Zoppoli G, Moran E, Soncini D, Cea M, Garuti A, Rocco I, et al. Ras-induced resistance to lapatinib is overcome by MEK inhibition. Curr Cancer Drug Targets. 2010;10(2):168–75.

4. Van Cutsem E, Kohne CH, Hitre E, Zaluski J, Chang Chien CR, Makhson A, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009;360(14):1408–17.

5. Sorich MJ, Wiese MD, Rowland A, Kichenadasse G, McKinnon RA, Karapetis CS. Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials. Ann Oncol. 2015;26(1):13–21.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

2. The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors;Cancers;2024-04-19

3. Concurrent NRAS-BRAF variants in metastatic colorectal cancer: a Tunisian case report;Anti-Cancer Drugs;2024-03-05

4. KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer;International Journal of Molecular Sciences;2023-08-13

5. Clinical, Pathological and Molecular Insights on KRAS, NRAS, BRAF, PIK3CA and TP53 Mutations in Metastatic Colorectal Cancer Patients from Northeastern Romania;International Journal of Molecular Sciences;2023-08-11